One of the first and thus best-studied epigenetic modifications in the wide spectrum of neoplasia, including gliomas, is O6-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation [14,15]. Here, MGMT is linked to central nervous system cancer.